Search results
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 3 days agoEli Lilly & Co.'s shares climbed in early US trading after its experimental drug for Alzheimer's...
A Guide to Managing COVID This Summer
New York Times· 1 day agoHere’s what to know about symptoms, testing and treatment. As new variants of the coronavirus continue to gain traction, doctors and researchers are...
Alzheimer’s Disease Drug Donanemab Gets Unanimous Backing From FDA Expert Panel
Forbes· 3 days agoA Food and Drug Administration expert panel of advisors voted 11-0 yesterday to recommend that the...
How A New Covid-19 Antibody Could Contribute To Advanced Vaccine Development
Forbes· 7 days agoIn the ongoing Omicron era, a new Covid-19 antibody could renew optimism for urgently required...
FDA panel votes unanimously for Eli Lilly's Alzheimer's treatment
Yahoo Finance· 3 days agoAn FDA panel voted 11-0 Monday to recommend the use of Eli Lilly's (LLY) early-stage Alzheimer's...
Eli Lilly's Alzheimer's Drug Gains Unanimous FDA Panel Backing
Verywell Health via Yahoo News· 2 days agoAn FDA advisory panel endorsed donanemab, Eli Lilly’s monoclonal antibody drug designed to slow the...
'Healed on the inside': Polk man chronicles how God and family got him through cancer fight
The Ledger via Yahoo News· 10 hours agoDoctors decided that Foley was a candidate for immunotherapy, a protocol intended to help the...
“Inoculation” to Resist Misinformation
Journal of the American Medical Association· 3 days agoThe global spread of false and misleading information poses serious threats to public health by promoting vaccine hesitancy, non–evidence-based therapies (eg, “natural” remedies), and even the ...
AbbVie inks immune disorder drug licensing deal with China's FutureGen
Reuters via Yahoo News· 9 hours agoAbbVie has been counting on its newer immunology medicines to help make up for declining sales of...
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab
CNN via Yahoo News· 3 days agoOn Monday, a panel of independent advisers to the US Food and Drug Administration voted to endorse Eli Lilly’s drug donanemab, a monoclonal antibody designed ...
